ArticleCyborg and bionic systems (Washington, D.C.)2026
Hierarchical Tissue-Specific Modeling of Pathology Images Predicts Response in HER2+ Breast Cancer.
Article in Cyborg and bionic systems (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The structural and spatial heterogeneity of the tumor microenvironment in human epidermal growth factor receptor 2-positive (HER2+) breast cancer (HER2+BC) poses major challenges for predicting pathologic complete response (pCR) to neoadjuvant chemotherapy. While immune-related biomarkers from whole-slide images have been widely explored, tissue-level interaction patterns and semantic features remain underexplored, particularly in characterizing structural organization within tissue compartments. To address this, we propose an interpretable hierarchical framework that models the tissue-specific organization of graph-based structural features and deep-learning-derived pCR scores (DLPSs) and integrates clinical variables to enhance pCR prediction. Whole-slide images were segmented into 5 biologically distinct compartments: tumor, stroma, stromal tumor-infiltrating lymphocytes (sTILs), intratumoral tumor-infiltrating lymphocytes (iTILs), and combined tumor-infiltrating lymphocytes (sTILs plus iTILs). Each compartment was modeled as a graph in which tile-level cluster centers served as nodes and their connections as edges. Structural features were computed using social network analysis (SNA) metrics to characterize spatial organization in each tissue compartment. In parallel, DLPSs were generated using a pretrained clustering-constrained multiple-instance learning model as a feature extractor, followed by training tissue-specific multilayer perceptron classifiers. The tissue-specific SNA features, DLPSs, and clinical variables were integrated for prediction. The model was trained on the Yale Response dataset and externally validated using the IMage-based Pathological REgistration and Segmentation Statistics (IMPRESS) HER2+ dataset. Across compartments, stroma achieved the highest predictive performance (area under the receiver operating characteristic curve [AUC] = 0.907), surpassing a reported method by 9.5%. Notably, SNA features achieved an AUC of 0.793, outperforming DLPS (0.596) and clinical variables (0.757). These findings suggest the value of integrating tissue-specific structural and semantic features for interpretable modeling of treatment response variability in HER2+BC.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.